000 square metres of factory space, with two standardized plants, nearly 10 million of assets, primarily production Laifumite, min Lok organism, Hong Hei pain medicine raw materials and intermediate, with sales of about 50 million yuan, products sell to d
000 square metres of factory space, with two standardized plants, nearly 10 million of assets, primarily production Laifumite, min Lok organism, Hong Hei pain medicine raw materials and intermediate, with sales of about 50 million yuan, products sell to d
工厂占面积3万平方米，拥有两座标准化厂房，资产近千万元，主要生产来氟米特，敏乐啶，痛喜康医药原料及其中间体等，年销售额约五千万元，产品远销欧洲、东南亚等地。